We are live on ! Find out more
DTIL icon

Precision BioSciences
DTIL

52 hedge funds and large institutions have $18.6M invested in Precision BioSciences in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 8

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

8% more funds holding

Funds holding: 48 → 52 (+4)

3.89% more ownership

Funds ownership: 36.13% → 40.02% (+3.9%)

3% more capital invested

Capital invested by funds: $18.1M → $18.6M (+$575K)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
52
Holders Change
+4
Holders Change %
+8.33%
% of All Funds
0.68%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
11
Increased
14
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BL
Bleichroeder LP
New York
+$5.24M
2
LCM
Lynx1 Capital Management
Puerto Rico
+$1.33M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$613K
4
Corient Private Wealth
Corient Private Wealth
Florida
+$499K
5
BCM
Bridgeway Capital Management
Texas
+$305K

Top Sellers

Rank Fund Capital Flow
1
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$905K
2
Millennium Management
Millennium Management
New York
-$313K
3
MSAM
Moloney Securities Asset Management
Missouri
-$204K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$112K
5
TCM
Tang Capital Management
California
-$97.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
VC
26
Vivo Capital
California
$19.6K – – –
CIA
27
Cape Investment Advisory
Georgia
$14.7K +$17.3K +3,500 New
Raymond James Financial
28
Raymond James Financial
Florida
$8.27K +$9.71K +1,969 New
NFSG
29
Newbridge Financial Services Group
Florida
$6.72K – – –
Carson Wealth (CWM LLC)
30
Carson Wealth (CWM LLC)
Nebraska
$4K – – –
Citigroup
31
Citigroup
New York
$3.88K +$4.55K +923 New
TRCT
32
Tower Research Capital (TRC)
New York
$3.66K -$3.1K -628 -42%
SS
33
SBI Securities
Japan
$1.98K +$5 +1 +0.2%
Barclays
34
Barclays
United Kingdom
$1.61K – – –
RhumbLine Advisers
35
RhumbLine Advisers
Massachusetts
$1.16K – – –
Bank of America
36
Bank of America
North Carolina
$689 +$158 +32 +24%
FFO
37
Fortitude Family Office
Arizona
$407 +$479 +97 New
SC
38
SouthState Corp
Florida
$399 – – –
BNP Paribas Financial Markets
39
BNP Paribas Financial Markets
France
$344 +$133 +27 +49%
Osaic Holdings
40
Osaic Holdings
Arizona
$315 +$370 +75 New
Jones Financial Companies
41
Jones Financial Companies
Missouri
$301 +$345 +70 New
Zurich Cantonal Bank
42
Zurich Cantonal Bank
Switzerland
$290 – – –
PS
43
Principal Securities
Iowa
$290 +$340 +69 New
Wells Fargo
44
Wells Fargo
California
$286 +$163 +33 +94%
AWM
45
Ameliora Wealth Management
Switzerland
$139 – – –
NA
46
NewEdge Advisors
Louisiana
$91 – – –
FDCDDQ
47
Federation des caisses Desjardins du Quebec
Quebec, Canada
$50 – – –
IRC
48
Investors Research Corp
Georgia
$34 – – –
JP Morgan Chase
49
JP Morgan Chase
New York
$34 – – –
MCM
50
MAI Capital Management
Ohio
$30 – – –
1
2
3

DTIL Hedge Fund Activity: Q2 2025 in Review

52 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2025, worth a combined $18.6M — up 3.2% from $18.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new DTIL positions and 7 closed out — a net gain of 4 holders — while 14 added to existing stakes and 8 trimmed.

The largest buyer was Bleichroeder LP, adding an estimated $5.24M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $905K sold.

  • 52 institutional investors held Precision BioSciences (DTIL) as of Q2 2025, up from 48 in Q1 2025.
  • Funds reported $18.6M of Precision BioSciences stock for Q2 2025, up 3.2% quarter-over-quarter.
  • 11 funds opened new Precision BioSciences positions in Q2 2025 and 7 closed out, a net change of +4 holders.
  • The largest Precision BioSciences buyer in Q2 2025 was Bleichroeder LP, an estimated $5.24M added.
  • The largest Precision BioSciences seller in Q2 2025 was Balyasny Asset Management, an estimated $905K sold.

Based on aggregated 13F filings for Q2 2025.